Lubio Science Webinar: PARP inhibition restores MAPK inhibitor sensitivity in melanoma 05.05.22 16:00-17:00
Date and Time: Thursday, May 5th at 16:00 CET – 17:00 CET Webinar title: PARP inhibition restores MAPK inhibitor sensitivity in melanoma Description: “Cutaneous malignant melanoma is the most aggressive type of skin cancer and is responsible for approximately 75% of all skin tumor deaths. Inhibitors of the MAPK signaling pathway (MAPKi) have become important…
Read more